AI 摘要
我们查看了 xeljanz xr 的 27 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Prescription Drugs 和 Pharmaceutical。
Compare with TopFind
实时搜索
正在加载实时结果
TopFind 正在为你的搜索抓取最新匹配结果。
实时搜索
TopFind 正在为你的搜索抓取最新匹配结果。
我们查看了 xeljanz xr 的 27 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Prescription Drugs 和 Pharmaceutical。
来源: Pfizer (Thailand) Ltd.
描述
XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required.
适用场景
Once Daily dosing, Long Term maintenance 和 Chronic inflammation management
评分
来源: Watsons Philippines
描述
The 11mg extended-release (XR) version of Xeljanz (tofacitinib) offered by Watsons Philippines. This formulation provides a steady release of medication and is intended for patients requiring a higher once-daily dosage as prescribed by a medical professional.
适用场景
Once Daily dosage users, Extended Release medication, Chronic inflammatory conditions 和 Online pharmacy users
评分
来源: Pfizer
描述
Xeljanz is a prescription Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis. As a brand-name pharmaceutical, it is available in 5mg immediate-release and 11mg extended-release (XR) tablet formulations designed to reduce inflammation and manage symptoms of autoimmune diseases.
适用场景
Rheumatoid arthritis patients, Prescribed JAK inhibitors, Autoimmune disease management 和 Ulcerative colitis treatment
评分
| 比较 | XELJANZ XR | Xeljanz 11mg XR Tablet | Xeljanz (tofacitinib) |
|---|---|---|---|
| 来源 | Pfizer (Thailand) Ltd. | Watsons Philippines | Pfizer |
| 描述 | XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required. | The 11mg extended-release (XR) version of Xeljanz (tofacitinib) offered by Watsons Philippines. This formulation provides a steady release of medication and is intended for patients requiring a higher once-daily dosage as prescribed by a medical professional. | Xeljanz is a prescription Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis. As a brand-name pharmaceutical, it is available in 5mg immediate-release and 11mg extended-release (XR) tablet formulations designed to reduce inflammation and manage symptoms of autoimmune diseases. |
| 适用场景 | Once Daily dosing, Long Term maintenance 和 Chronic inflammation management | Once Daily dosage users, Extended Release medication, Chronic inflammatory conditions 和 Online pharmacy users | Rheumatoid arthritis patients, Prescribed JAK inhibitors, Autoimmune disease management 和 Ulcerative colitis treatment |
| 操作 | |||
| 评分 |
如果你想先看最均衡的选择，我推荐：
"XELJANZ XR 来自 Pfizer (Thailand) Ltd.."
我选择它是因为 Offers the convenience of once-daily dosing through its extended-release formulation, supported by Pfizer's official clinical standards.